Status:
ENROLLING_BY_INVITATION
Palliative Care for Patients With Liver Cirrhosis
Lead Sponsor:
Esbjerg Hospital - University Hospital of Southern Denmark
Collaborating Sponsors:
Herlev Hospital
Aarhus University Hospital
Conditions:
End of Life Care
Liver Cirrhosis
Eligibility:
All Genders
18+ years
Brief Summary
Background: Patients with liver cirrhosis rarely receive palliative care although the Danish Health Authorities and WHO recommend it. The lacking palliative intervention is probably owed to a physicia...
Eligibility Criteria
Inclusion
- Liver cirrhosis of any etiology (diagnosed clinically, by imaging or histological features) as predominant chronic illness
- 2 or more items checked on the Supportive and Palliative Care Indicators Tool (SPICT™, appendix)
- Expressed desire for palliative support from the patient and relatives
- Ability to give informed consent
Exclusion
- Inability to give informed consent
- Age \< 18 years
- Ongoing contact with specialized palliative care teams or hospice
- Other chronic life-threatening illness than liver cirrhosis is more likely to become the cause of death within 1-2 years.
Key Trial Info
Start Date :
August 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2028
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05431946
Start Date
August 1 2023
End Date
August 1 2028
Last Update
March 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital of South West Jutland
Esbjerg, Denmark, 6700